RE:RE:RE:Hi all, I think many would be pleased to see Onc be bought out by a Roche.
They certainly know Onc/ Palareorep clinical potential.
They have been working alongside , with ONC for a very long time.
Again, endorsement from CGAR to $5million grant.FDA favourable directions,
including fast track designation for MBc & panc cancer.
With discussions of potential accelerated approval.
All "value added" accomplishments.
As notable has posted, many junior biotechs, have been bought out for $billions, offering much less than Onc has to offer.
My advice , not changed.
price is silly low right now. If you belive in the science, time to buy.
Certainly not time to sell.
im holding , until they succeed or fail.
right now, ALL the recent news updates are very positive.
They need to spin that into a deal.
Roche a great option.